|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
INCREASED SEDATIVE EFFECT
|
CAPREOMYCIN HAS SOME OF ITS OWN NEUROMUSCULAR BLOCKING ACTION WHEN GIVEN IN LARGE DOSES, WHICH IS ENHANCED BY ETHER
|
SYNERGISTIC EFFECT OF INTERFERENCE WITH NERVE TRANSMISSION AT NEUROMUSCULAR JUNCTION WARRENT CAREFUL USE
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CO-ADMINISTRATION MAY INCREASE CHANCES OF POSTOPERATIVE RESPIRATORY DEPRESSION OR ENHANCE IT
|